Search clinical trials for: Levetiracetam 166 mg

Total 11872 results

Luye Pharma Group Ltd.
Shandong Luye Pharmaceutical Co., Ltd.

Completed

Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LY03005 Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)

Major Depressive Disorder

China
Tanta University

Unknown

Levetiracetam Versus Phenytoin in Management of Pediatric Status Epilepticus

Comparison | the Efficacy of Levetireacetam | Phenytoin | Management of Pediatric Status Epilepticus

Egypt
Thymon, LLC

Completed

Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected Subjects (THYMON-10001)

HIV Infections

United States
Hoffmann-La Roche

Completed

A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Rheumatoid Arthritis

Poland, United States, Colombia, Brazil, Canada, South Africa, Spain, Greece, Russian Federation, Switzerland, Thailand, Bulgaria, Israel, Mexico, Hungary, Argentina, Panama, Philippines, Guatemala, Malaysia, Australia, New Zealand
UMC Utrecht

Completed

Radioactive Holmium Microspheres for the Treatment of Liver Metastases (HEPAR)

Liver Tumors | Liver Metastasis

Netherlands
Novartis

Completed

A Study of Valsartan Administered Once Daily Versus Twice Daily, in Patients With Stable, Chronic Heart Failure

Chronic Heart Failure

United States
Poniard Pharmaceuticals

Terminated

A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma

Multiple Myeloma
Nearmedic Plus LLC
OCT LLC

Completed

Phase 1 Study of PBTZ169

Tuberculosis
Regeneron Pharmaceuticals

Completed

Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)

Genetic Diseases, Inborn | Familial Cold Autoinflammatory Syndrome (FCAS) | Familial Cold Urticaria | Muckle-Wells Syndrome (MWS)

United States
VA Office of Research and Development

Active, not recruiting

Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia

Schizophrenia

United States
NYU Langone Health
National Institutes of Health (NIH)

Completed

Levetiracetam in Early Psychosis

Schizophrenia | Psychosis | Schizo Affective Disorder | Schizophreniform

United States
Indiana University

Terminated

Seizure Prophylaxis in Aneurysm Repair

Seizures | Intracranial Aneurysms

United States
UCB Pharma

Completed

Conversion to Monotherapy Study With Keppra XR for Partial Seizures

Epilepsy

Poland, United States, Mexico, Russian Federation
Teva Pharmaceuticals USA

Completed

Levetiracetam 750 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 750 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Levetiracetam 1000 mg Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Levetiracetam 1000 mg Under Non-Fasting Conditions

Healthy

United States
UCB Pharma

Completed

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

Epilepsy
UCB Pharma

Completed

Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old

Epilepsy
University of California, San Francisco
UCB Pharma

Completed

Levetiracetam for Treatment of Pain Associated With Fibromyalgia

Fibromyalgia

United States
UCB Pharma

Completed

Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam

Epilepsy

Spain
University of Colorado, Denver

Recruiting

Effects of Low-dose Levetiracetam on Clinical Symptoms, Cognition and Hippocampal Hyperactivity in Schizophrenia

Schizophrenia

United States
UCB Pharma

Completed

Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy

Epilepsy, Partial

Hong Kong, Malaysia, Philippines, Singapore, Taiwan, Thailand
Loyola University

Unknown

Does Short-Term Anti-Seizure Prophylaxis After Traumatic Brain Injury Decrease Seizure Rates?

Seizures | Traumatic Brain Injury

United States
Berkshire Health Systems
UCB Pharma

Completed

Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder (PMDD) (pmdd)

Premenstrual Dysphoric Disorder

United States
Pacira Pharmaceuticals, Inc

Completed

Femoral Nerve Block With Liposome Bupivacaine for Postsurgical Analgesia Following Total Knee Arthroplasty

Postoperative Pain

United States
SocraTec R&D GmbH
SocraMetrics GmbH; Teikoku Seiyaku Co., Ltd.

Completed

S-flurbiprofen Bioavailability Trial to Compare a Newly Developed Patch vs. a Marketed Tablet

Comparative Bioavailability

Germany
National Institute of Mental Health (NIMH)
Taisho Pharmaceutical Co., Ltd.

Recruiting

Antidepressant Effects of TS-161 in Treatment-Resistant Depression

Depression | Major Depressive Disorder | Treatment-Resistant Depression

United States
University of Florida

Completed

1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients

Brain Neoplasms | Brain Cancer | Brain Tumors | Seizure | Cancer of the Brain | Cancer of Brain

United States
UCB Japan Co. Ltd.

Completed

A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)

Epilepsy | Generalized Tonic-Clonic Seizures

China, Japan
Walter Reed National Military Medical Center

Not yet recruiting

Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE) (LAPSE)

Alzheimer Disease

United States
Beth Israel Deaconess Medical Center

Recruiting

Treating Hyperexcitability in AD With Levetiracetam (LeAD)

Alzheimer Disease | Mild Cognitive Impairment | Alzheimer Dementia | Dementia of Alzheimer Type

United States
University of Oxford
UCB Pharma; Oxford University Hospitals NHS Trust; Oxford Health NHS Foundation... and other collaborators

Completed

An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD)

Epilepsy | Alzheimer Disease

United Kingdom
UCB Pharma

Completed

A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy

Epilepsy, Partial
Technische Universität Dresden
UCB Pharma GmbH

Completed

Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease (LeLeDys)

Parkinson's Disease

Germany
UCB Pharma

Completed

Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias

Idiopathic Parkinson Disease
UCB Pharma

Completed

Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial Epilepsy

Epilepsy
ayesha tariq
King Edward Medical University

Recruiting

Comparison of Efficacy of Phenytoin With Levetireacetam for the Management of Children With Status Epilepticus

Status Epilepticus

Pakistan
UroGen Pharma Ltd.

Completed

Safety of Pre-TURBT Intravesical Instillation of Escalating Doses of TC-3 Gel and MMC in NMIBC Patients

Neoplasms | Urologic Diseases | Urinary Bladder Diseases | Bladder Cancer

Israel
HK inno.N Corporation

Completed

Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia

Hypertension With Hyperlipidemia
Novartis Pharmaceuticals

Completed

Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications (Navigator)

Diabetes Mellitus, Type 2

Austria, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Ecuador, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Italy, Malaysia, Mexico, Netherlands, Norway, Peru, Poland, Russian Federation and more
Deutsches Herzzentrum Muenchen
German Federal Ministry of Education and Research; Technical University of... and other collaborators

Completed

Intracoronary Stenting and Antithrombotic Regimen: Lesion Platelet Adhesion as Selective Target of Endovenous Revacept (ISAR-PLASTER)

Stable Coronary Artery Disease

Germany
Yale University
Stanley Medical Research Institute

Completed

Levetiracetam in the Management of Bipolar Depression

Bipolar Depression

United States
UCB Japan Co. Ltd.

Completed

A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures

Epilepsy | Generalized Tonic-clonic Seizures

Japan
UCB Pharma

Completed

An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese

Human Volunteers

China
Assistance Publique - Hôpitaux de Paris

Completed

Study of Antiepileptic Drug in Generalised Convulsive Status Epilepticus (SAMU-KEPPRA)

Status; Epilepticus, Tonic-clonic

France
Leiden University Medical Center
Medtronic; ZonMw: The Netherlands Organisation for Health Research and Development and other collaborators

Completed

Holmium Radioembolization as Adjuvant Treatment to RFA for Early Stage HCC: Dose Finding Study (HORA EST HCC)

HCC | Early Stage HCC

Netherlands
Brigham and Women's Hospital

Completed

Add on Lacosamide Versus High Dose Monotherapy

Epilepsy

United States
UCB Pharma

Completed

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

Epilepsy | Generalized Tonic-clonic Seizures

Japan
Ache Laboratorios Farmaceuticos S.A.

Completed

Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization (Mozart)

Epilepsy | Partial Seizures

Search clinical trials for: Levetiracetam 166 mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations